GE Healthcare will pay $30 million to the CMS and to a Michigan representative of competitor Bristol-Myers Squibb to settle a federal lawsuit alleging overbilling for the drug Myoview.
Whistle-blower suit ends up costing GE $30 million
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.